Rel, a haemopoietic cell-restricted member of the NF-κB/Rel family of transcription factors, has recently been shown to be important in the function of B and T lymphocytes. In an attempt to understand the role of this protein in the immune response, we examined the ability of Rel -/-mice to counter an influenza virus infection. Normal levels of virus-specific cytotoxic T cells induced in Rel -/-mice were able to clear virus from the lungs, albeit with somewhat delayed kinetics compared to normal mice. Rel -/-mice did, however, display a markedly reduced T cell proliferative response to the virus, and exhibited impaired local and systemic influenza virus-specific antibody responses. This defect was sufficient to result in an inability of vaccinated mice, but not of previously infected mice, to acquire antibody-dependent protective immunity to reinfection with the same virus. These findings establish that during the response to influenza virus, Rel function allows optimal development of humoral immunity, a role that apparently cannot be fulfilled by other NF-κB/Rel proteins.
Introduction
The c-rel gene encodes a subunit (Rel) of the homo-and heterodimeric family of NF-κB/Rel transcription factors. In vertebrates, Rel and other members of the family, including RelA (p65), RelB, NF-κB1(p50) and NF-κB2(p52), share a conserved N-terminal domain of~300 amino acids containing sequences necessary for DNA binding, subunit dimerization and nuclear localization (1) . In most cell types, these transcription factors reside in the cytoplasm in an inactive form due to association with inhibitory proteins collectively termed IκBs. A diverse range of different stimuli lead to the activation of cytoplasmic NF-κB/Rel complexes as a result of IκB phosphorylation which targets the inhibitor for proteosome-mediated degradation (2, 3) . The NF-κB/Rel proteins are then translocated to the nucleus where these factors bind to DNA haemopoietic cells, Rel is mainly found in association with NF-κB1 or RelA (7) .
Despite the detailed biochemical and molecular characterization of the different NF-κB/Rel complexes, particularly in lymphocytes, little is known about their specific roles in the immune response to infection. The ability to gain further insight in this area has recently been made possible by the generation of mutant mice which lack various NF-κB/Rel subunits (15) (16) (17) . Rel -/-and NF-κB1 -/-mice have normal numbers of haemopoietic cells, indicating that these transcription factors are not essential for haemopoiesis (15, 16) . However, mature splenic B and T cells from Rel -/-mice fail to respond to most mitogenic stimuli in culture (15) , and the production of various cytokines by Rel -/-T cells and macrophages is impaired (18, 19) . NF-κB1 -/-B cells also exhibit a reduced proliferative response to mitogens (16) . Consistent with the impaired B cell proliferation, Rel -/-and NF-κB1 -/-mice display a diminished humoral response when challenged with model antigens (15, 16) . RelB -/-mice develop an inflammatory disease that appears to be due to aberrant T cell development (17) . While death of RelA -/-mice during embryogenesis (20) has prevented a detailed analysis of the role of RelA in immune responses, B and T lymphocytes isolated from RAG-1 -/-mice reconstituted with RelA -/-fetal liver cells exhibit proliferative defects in culture (21) .
Although in vitro studies have identified defects in the function of lymphocytes from the various NF-κB/Rel-deficient mice, the capacity of these mice to mount an immune response to various pathogens remains unclear. In the case of the Rel -/-mice, increased susceptibility to Leishmania major, an intracellular parasite, was linked to reduced cytotoxic killing by Rel -/-macrophages (19) . NF-κB1 -/-mice were found to be highly susceptible to staphylococcal infection (16) ; however, the immunological basis of this phenotype remains to be determined.
Here we examine the ability of Rel -/-mice to mount antiviral immune responses induced by either infection or vaccination. We show that when infected with influenza virus, Rel -/-mice can clear the virus from their lungs and have functional cytotoxic T cells. However, they fail to develop the same high titres of serum anti-viral antibody and virus-neutralizing antibody achieved by their Rel ϩ/ϩ counterparts. In addition, local influenza virus-specific antibody responses are impaired and these animals display a markedly reduced proliferative T cell response to the virus. Despite this, previously infected Rel -/-mice have sufficient humoral immunity to allow protection against reinfection with the same virus. Vaccine-induced responses, however, were insufficient to protect Rel -/-mice from reinfection.
Methods

Mice
The B6 Rel -/-and Rel ϩ/ϩ mice were generated as previously described by Kö ntgen et al. (15) .
Virus
The influenza virus used was Mem 71 (subtype H3N1) virus, a genetic reassortant of A/Memphis/1/71(H3N2)ϫA/Bellamy/ 42 (H1N1). The virus was grown for 2 days in the allantoic cavities of 10-day-old embryonated hen's eggs, harvested and stored in aliquots at -70°C. Purified Mem 71 virus was supplied by CSL Limited (Parkville, Victoria, Australia) and was stored at 4°C in PBS with 0.1% sodium azide. Virus titres were determined by the haemagglutination assay (22) and expressed as haemagglutinating units (HAU)/ml. Infectious virus titres, used for quantitation of the intranasal (i.n.) infection dose, were obtained by assay of plaque formation in monolayers of Madin Darby canine kidney (MDCK) cells (23) and expressed as p.f.u./ml.
Immunization and challenge of mice Mice were infected by the i.n. route, under penthrane anaesthesia, with 10 4.5 p.f.u. of Mem 71 virus in 50 µl PBS or immunized by the s.c. route in the scruff of the neck with 200 µl of virus solution containing 1000 HAU of virus. Proliferative T cell assays were carried out either with spleen cells taken 7 weeks after i.n. infection or with inguinal and popliteal lymph nodes taken 7 days after s.c. inoculation in the hind footpads with 10,000 HAU of purified virus in incomplete Freund's adjuvant (IFA; Sigma, St Louis, MO).
Cell culture medium T cell culture medium consisted of RPMI 1640 (CSL) supplemented with 10% (v/v) heat-inactivated (56°C, 30 min) FCS, 2 mM L-glutamine, 2 mM sodium pyruvate, 30 µg/ml gentamycin, 100 µg/ml streptomycin, 100 IU/ml penicillin and 0.1 mM 2-mercaptoethanol.
Preparation of lung, spleen and lymph node cells Lungs were removed after i.n. infection with influenza virus and the cells used as primary effectors in the cytotoxic T cell assay (6 days post-infection) or as a source of B cells in the ELISPOT assay (4, 6, 8 and 10 days post-infection). For the cytotoxic assay, lungs from individual mice were minced and digested with collagenase A (from Clostridium histolyticum; Boehringer, Mannheim, Germany; 4 mg per set of lungs in 2 ml RPMI 1640 supplemented with 2 mM L-glutamine, 100 µg/ml streptomycin and 100 IU/ml penicillin) for 30 min at 37°C. Single-cell suspensions were produced by passing the digest through a wire mesh and the resulting cells were depleted of erythrocytes by treatment with Tris-buffered ammonium chloride (ATC; 0.15 M NH 4 Cl in 17 mM Tris-HCl at pH 7.2). The lymphocytes were purified by centrifugation over Isopaque-Ficoll (24) .
For the ELISPOT assay, lungs were sieved through a wire mesh, the resulting cell populations were ATC-treated, and any large clumps of debris that accumulated in these preparations after washing were allowed to settle and then removed prior to addition of cells to the wells. Mediastinal lymph node (MLN) cells used in these assays were also prepared by sieving and ATC treatment.
Spleen cells used in cytotoxic T lymphocyte (CTL) and proliferative T cell assays were similarly sieved and treated with ATC prior to re-stimulation in vitro or addition to nylon wool columns respectively. Inguinal and popliteal lymph nodes, used in the proliferative T cell assay, were sieved through wire mesh, washed and used without further treatment.
ELISA
ELISA was performed on sera from mice bled via the retroorbital plexus. The assay was carried out as previously described (25) using 96-well polyvinyl chloride microtitre trays (Dynex Technologies Inc., Chantilly, VA) coated with 50 µl of a solution containing 1000 HAU of purified virus/ml. Antibody titres are expressed as the reciprocal of the antibody dilution giving an absorbance of 0.2 U.
ELISA was also used to examine the isotype profiles of influenza virus-specific Ig in the serum samples. Rabbit antimouse isotyping reagents (ICN, Costa Mesa, CA) were used for this determination as previously described (26) . Antibody titres were expressed as the reciprocal of the dilution of antiserum giving an absorbance of 0.2 U above the background obtained with the relevant isotyping reagent.
ELISPOT assay
Influenza virus-specific antibody-secreting cells (ASC) were enumerated by an ELISPOT assay (27) based on that described by Segwick and Holt (28) . Briefly, 200 HAU of purified virus/well were added to 96-well flat-bottomed polyvinyl microtitre plates (Dynex Technologies Inc.) and the plates incubated overnight in a humidified atmosphere at room temperature. Wells were then exposed to PBS containing 10% BSA to block remaining sites. After 1 h incubation, the plates were washed 3 times with PBS containing 0.05% Tween 20 (PBST) and then 50 µl of T cell medium was added to each well. Aliquots (50 µl) of ATC-treated lung and MLN cell suspensions were added to replicate wells, and six serial 2-fold dilutions performed. The plates were then placed in a vibration-free incubator at 37°C in 5% CO 2 overnight. After incubation, the cells were lysed and removed by rinsing the plates twice with distilled water and twice with PBST. Rabbit anti-mouse isotyping reagents (ICN), diluted 1:400 in PBST containing 0.5% BSA, were added in 50 µl/well to duplicate titration series and the plates further incubated for 2 h in a humidified atmosphere. Plates were then washed 3 times with PBST and 50 µl/well of alkaline phosphatase-conjugated sheep anti-rabbit Ig (Silenus Laboratories, Hawthorn, Victoria, Australia; 1:1000 dilution in PBST containing 0.5% BSA) was added and incubated for a further 2 h in a humidified atmosphere. The plates were rinsed with PBST 3 times and once with distilled water. The assay was then developed by adding to each well 50 µl of ELISPOT substrate, which contained 1 mg of 5-bromo-4-chloro-3-indolyl phosphate (5-BCIP) per ml in 2-amino-2-methyl-1-propanol (AMP) buffer (28) . After 30 min at room temperature green spots appeared, each spot representing a single ASC. The plates were washed 3 times with distilled water and spots counted using an inverted microscope. Results are expressed as the number of ASC (ELISPOTS)/10 6 cells.
Plaque assay for infectious virus
Lungs were removed, individually washed in HBSS, and transferred to a bijou bottle containing 1.5 ml HBSS supplemented with 100 IU of penicillin/ml, 100 µg of streptomycin/ ml and 30 µg of gentamycin/ml and kept on ice. The tissue was disrupted by passage through a wire mesh sieve. The cells and debris were removed by centrifugation (300 g, 5 min) and the supernatant stored in aliquots at -70°C. Virus titres of the lung supernatants were determined by plaque assay on monolayers of MDCK cells (23) .
Neutralization assay
Neutralization of virus infectivity was determined by measuring plaque reduction on MDCK monolayers (27) . All sera were heat inactivated (56°C, 1 h) and filtered before use. Serial dilutions of sera in RPMI 1640 containing antibiotics were preincubated with 100-150 p.f.u. of influenza virus in a total volume of 500 µl for 30 min at 37°C. One hundred microlitres of the mixtures was applied to duplicate washed MDCK cell monolayers. After absorption of virus for 45 min at 37°C (5% CO 2 ), 3 ml of agarose overlay medium, prewarmed to 45°C, was added. After 3 days incubation (37°C, 5% CO 2 ) the plaques were counted and the neutralization titre was determined as the reciprocal of the mean dilution of serum that resulted in a 50% reduction in the number of plaques obtained with virus alone.
Primary cytotoxic T cell assay
The cells used as targets in the cytotoxic T cell assay were EL4 (H-2 b ) tumor cells. Virus-infected and uninfected targets were prepared by incubating 2ϫ10 6 EL4 cells in 500 µl of infectious virus solution (4000 HAU/ml) or serum-free RPMI, respectively. After 1 h incubation at 37°C, cells were washed once and resuspended in 200 µl of T cell medium containing 200 µCi 51 Cr (Amersham). After 2 h incubation at 37°C the cells was washed 3 times and their concentration adjusted to 10 5 cells/ml. One hundred microlitre aliquots of target cells were then dispensed into 96-well U-bottom tissue culture plates.
Purified lung lymphocytes were resuspended in T cell medium and added to the wells at various E:T cell ratios, in 100 µl. Cells were gently pelleted by centrifugation of the plates (1000 r.p.m., 30 s). After the target and effector cells had been incubated together at 37°C for 4 h in 5% CO 2 , 100 µl of supernatant were removed from each well and the amount of radioactivity determined using a γ-counter. The specific 51 Cr release at each E:T ratio is calculated by subtraction of the c.p.m. released spontaneously in wells containing target cells incubated with medium only. These values are then expressed as a percentage of the maximal releasable counts derived from the c.p.m. in samples from wells in which the target cells are incubated in detergent, minus the spontaneous release c.p.m. Spontaneous release usually ranged from 1 to 10% of the maximum releasable counts. Data are presented as the mean of the values obtained from triplicate cultures.
Secondary cytotoxic T cell assay
Secondary effector CTL were generated from the spleen cells of individual mice infected 4 weeks previously by the i.n. route (27) . Briefly, 4ϫ10 7 spleen cells, depleted of erythrocytes by treatment with ATC, were cultured in 25 cm 3 tissue culture flasks (Corning) containing 15 ml of T cell medium. Of these, 1ϫ10 7 cells had been incubated at 37°C for 30 min with 3000 HAU of infectious virus in 1 ml of serum-free RPMI and washed once prior to addition to the flask. After 5 days of culture at 37°C in a humidified atmosphere containing 5% CO 2 the cells were washed 3 times and used in the 51 Crrelease assay described above.
T cell proliferation assay
Spleen cell suspensions were prepared from mice 7 weeks after i.n. infection and draining lymph node cell suspensions were prepared 7 days after s.c. immunization with purified virus. T cells were isolated from these suspensions by passage through nylon wool columns (29) . Proliferation assays were set up as previously described (30) in 96-well flat-bottomed tissue culture plates (Nunc, Roskilde, Denmark). Wells contained 3ϫ10 5 T cells, 3ϫ10 5 irradiated (2200 rad, 60 Co source) spleen cells from Rel -/-or Rel ϩ/ϩ mice as a source of antigenpresenting cells and various amounts of purified influenza virus, in a total volume of 250 µl. Cultures were incubated at 37°C in a humidified atmosphere containing 5% CO 2 for 4 days with the addition of 1 µCi [ 3 H]thymidine during the final 18 h. Cells were then harvested onto filter paper and the incorporation of radioactivity measured on a Packard Matrix 9600 direct β-counter.
Results
Rel -/-mice mount a CTL response and show only slightly delayed clearance of virus following influenza infection
To determine whether the absence of Rel affects the ability of mice to combat a virus infection, both Rel -/-and Rel ϩ/ϩ mice were infected i.n. with a non-lethal strain of influenza and the levels of infectious virus present in the lungs over the following 10 days were assessed. Although the Rel -/-mice were able to completely clear the pulmonary infection, the kinetics of clearance was somewhat delayed compared to normal mice (Fig. 1) . One of the major mechanisms involved in recovery from pulmonary influenza virus infection in the mouse model is known to be lysis of infected cells by CD8 ϩ virus-specific CTL which limits the amount of infectious progeny produced (31) . The developing antibody response is also an important mechanism of clearance (32). Athymic nude mice, which have potent innate immunity but lack CD8 ϩ CTL and also CD4 ϩ T cells to provide help for the production of virusspecific antibody, fail to recover from influenza (33) . Similarly, B cell-deficient mice cannot clear an influenza infection if they have been depleted of CD8 ϩ cells (34) .
To investigate which, if any, of the mediators of clearance are compromised in Rel -/-mice such that recovery is slightly delayed, we first examined the ability of these mice to mount a CTL response. Spleen cells from individual Rel ϩ/ϩ and Rel -/-mice given infectious virus by the i.n. route 4 weeks previously were re-stimulated in culture and examined for their ability to lyse virus infected targets. All mice showed high levels of specific anti-influenza CTL activity (Fig. 2) , the levels of lysis of infected targets above that observed with uninfected targets being similar between the two groups of mice. The activity of CTL effector cells was also assessed directly in lung cell populations taken 6 days after i.n. infection with influenza virus. Figure 3 shows that Rel -/-and Rel ϩ/ϩ mice have comparable levels of influenza-specific pulmonary CTL, indicating that the c-rel gene product is not essential for CD8 ϩ CTL induction, maturation and effector function.
Rel -/-mice display impaired serum antibody production and reduced numbers of ASC following exposure to virus Once infected or vaccinated, mice become resistant to subsequent re-infection with the same strain of virus due to the induction of virus-neutralizing antibody. Secretory IgA is thought to be important for protection of the upper respiratory tract, while IgG as a transudate from the serum into the lung can afford protection at that site. To examine whether the c-rel knockout mice can mount a normal humoral immune response to influenza virus, their serum anti-viral antibodies were analyzed after either i.n. infection or s.c. vaccination using a protocol known to elicit high titre serum-neutralizing antibody responses. Twenty-eight days post-inoculation, sera were collected from the mice and assayed for influenzaspecific antibody of different isotypes and for neutralizing activity. As seen in Fig. 4(A) , in infected mice, titres of antiviral antibody of each different isotype were found to be on average 8-to 30-fold lower in Rel -/-mice than in Rel ϩ/ϩ mice; virtually no IgM was produced in response to infection in the Rel -/-animals (note the higher background binding with the antiIgM reagent). Vaccinated mice (Fig. 4B) gave a similar picture except that the levels of antibody induced were relatively lower overall; the difference between the two groups of mice was at least 30-fold.
An in vitro assay measuring viral-neutralizing activity of these sera detected significant levels of neutralizing antibody in Rel ϩ/ϩ mice but not in the Rel-deficient animals. While this highlights another striking difference in the humoral response of the mice, this in vitro assay should not be used as an indicator of how well the mice would be protected against subsequent exposure to the virus; we have previously shown that mice with no demonstrable virus-neutralizing antibody can nevertheless be resistant to reinfection via an antibodydependent mechanism (27) .
The local humoral immune response to influenza infection was also examined. The isotype profile of influenza-specific ASC was determined by ELISPOT assay of cells isolated from the lungs and MLN, which drain the lungs, taken at various days after i.n. infection (Fig. 5) . In Rel ϩ/ϩ mice, the ASC reached a maximum on day 8 post-infection in both tissues. In the lungs, cells secreting IgA dominated, whereas in the MLN, although IgA ASC were still the most abundant on day 8, ASC of each other isotype made up a considerable proportion of the total response. In the mice lacking Rel, the numbers of influenza-specific ASC detected in both lungs and MLN were reduced by at least 80% with each of the isotypes being affected.
Virus-specific proliferative T cell responses are impaired in Rel -/-mice Rel -/-mice have known defects in both B cell and T cell function. Although the CD8 ϩ CTL response to influenza appears normal in these mice, it is possible that the CD4 ϩ T cell subset may be defective which could in turn be partially responsible for the weak serum antibody response to the virus seen in these mice. To investigate this, the ability of the virus to induce T cells in vivo that are capable of antigenspecific proliferation after in vitro re-stimulation was assessed in Rel -/-and Rel ϩ/ϩ mice. As shown in Fig. 6 , T cells from infected or vaccinated Rel -/-mice have a decreased ability to proliferate in response to influenza antigen compared to those from Rel ϩ/ϩ mice. These data also show that this deficiency is not a function of the difference in antigenpresentation capacity of cells from the two groups of mice as irradiated spleen cells from Rel ϩ/ϩ mice could not restore the response of Rel -/-T cells.
Ability of Rel -/-mice to be protected against reinfection with influenza virus
The inability of Rel -/-mice to mount a high-titred specific antibody response may have consequences for their ability to be protected against reinfection. This was examined by measuring the presence of infectious virus in the lungs of mice previously infected or vaccinated with virus and then challenged i.n. with the homologous virus (Fig. 7) . All Rel ϩ/ϩ and Rel -/-mice that had recovered from a previous infection were completely protected against the subsequent challenge (data not shown). Likewise, with the exception of one mouse in the day 3 group, vaccinated Rel ϩ/ϩ mice had no detectable virus present in their lungs following i.n. challenge. In contrast, however, four of the five vaccinated Rel -/-mice examined on day 3 were not protected against a subsequent i.n. challenge and displayed high titres of virus in their lungs. Virus was also observed in the lungs of some vaccinated Rel -/-mice on days 4 and 6 post-challenge. It is likely that the outcome of challenge in these mice was primarily determined by their level of humoral immunity prior to challenge; the relationship between virus titres and serum anti-viral antibody for the vaccinated mice examined on day 3 post-challenge is shown as an insert in Fig. 7 .
Discussion
The analysis of mice bearing null mutations in either Rel, NF-κB1, RelA or RelB has revealed that these proteins serve common as well as distinct roles in regulating the immune system. Rel, RelA and NF-κB1 all appear to belong to that class of NF-κB/Rel factors that are not essential for haemopoietic development, but instead are critical for the regulation of genes rapidly induced in response to stimuli that invoke an immune response. In haemopoietic cells, RelB serves a dual function; it is implicated in the regulation of genes associated with constitutive housekeeping functions as well as induced immune responses. In contrast to the individual mutants, the loss of both NF-κB1 and Rel prevents Fig. 4 . Titre of influenza-specific and neutralizing serum antibodies in Rel -/-and Rel ϩ/ϩ mice after infection or vaccination with virus. The sera obtained from five Rel -/-mice (s) and five Rel ϩ/ϩ mice (d), bled 28 days after i.n. infection (A) or s.c. vaccination (B) with virus, were assayed in an isotype specific ELISA for binding to purified virus. Individual influenza-specific antibody titres were obtained from the reciprocal of the dilution of antiserum giving an absorbance of 0.2 U above the background obtained with the relevant isotyping reagent. The sera were also assayed for the ability to neutralize infectious virus (right hand panels). The neutralization titres were obtained from the reciprocal of the mean dilution of serum that resulted in a 50% reduction in the number of plaques obtained with virus alone. The titre obtained with serum from mice prior to vaccination is represented with an asterisk. lymphopoiesis (35) , indicating that these subunits have both unique and redundant functions in haemopoietic cells.
In the present study, we have analyzed the immune response of Rel -/-mice to influenza, a model viral infection. A normal immune response evoked by this virus can be considered to occur in two phases. During primary infection of naive mice, effective clearance of influenza from the lungs is largely due to CD8 ϩ cytotoxic T cells but is aided by the developing humoral response. Resistance to secondary infection by the same viral strain is predominantly dependent on the production of high titre virus-neutralizing antibody. Our results show that naive Rel -/-mice infected i.n. appeared healthy and were able to completely clear a primary respiratory infection, albeit with a delay of 1-2 days compared to normal mice. The induction of a normal influenza-specific cytotoxic T cell response in Rel -/-mice indicates that Rel is not necessary for CTL induction. This differs from the RelB -/-mice in which the normal response to an acute infection with lymphocytic choriomeningitis virus is impaired due to a defective CTL response that arises from a markedly reduced expansion of CD8 ϩ T cells (36) . These findings reinforce the notion that different NF-κB/Rel proteins may serve specific roles in a cellular immune response.
Despite a normal CTL response, titres of serum antiviral antibodies of all isotypes are markedly reduced in the Rel -/-mice. This finding is consistent with the impaired response of these mice to haptenated keyhole limpet haemocyanin (a T-dependent antigen), in which the amount of antigen-specific IgG1 and IgG2a is dramatically less than in normal mice (15) . Moreover, we have shown that the number of ASC found at the site of infection in the lungs and the MLN is reduced in the infected Rel -/-mice. These findings most likely account for the delay in viral clearance observed after infection of Rel -/-mice and are compatible with the data derived in mice depleted of CD4 ϩ T cells which also show a slight delay in clearance of virus in the absence of a developing humoral response (37, 38) . The additional functional consequence of these defects in B cell clonal expansion and antibody secretion in Rel -/-mice was that the majority of animals receiving the s.c. vaccine, which is a less potent stimulator of humoral immunity than is infection, remained susceptible to sub- sequent exposure to virus rather than acquiring the life-long immunity that is normally induced. Infected Rel -/-mice, though producing substantially less anti-viral antibody than infected Rel ϩ/ϩ mice, nevertheless had levels similar to those in vaccinated Rel ϩ/ϩ mice and were likewise protected against re-infection.
The precise basis for the defective anti-viral humoral response remains unclear. Although a weak antibody response coupled with the reduced proliferative capacity of CD4 ϩ influenza-specific T cells isolated from Rel -/-mice when recalled in vitro with influenza virus is consistent with an inefficient CD4 ϩ T h response, an intrinsic defect in the function of Rel -/-B cells may also contribute to impaired isotype production in these mice. For example, surface IgM ϩ Rel -/-B cells fail to switch to IgG1, IgE and IgG2a in the cultures containing the T cell cytokines IL-4 or IFN-γ (G. Grigoriadis, R. Grumont and S. Gerondakis, unpublished results), and naïve Rel -/-mice show 100-fold less IgG1 and undetectable IgG2a in their serum compared to Rel ϩ/ϩ mice (15) . Furthermore, diminished expansion of antigen-specific B cell clones in vivo is consistent with previous findings showing that Rel is required for B cell proliferation in cultures stimulated with polyclonal mitogens (15) . In the future, it should be possible to use adoptive transfer experiments to determine if the restoration of the anti-influenza antibody response requires normal B or T cells, or whether both populations are required.
Of additional interest is the finding that an intact CD8 ϩ T cell response can occur in the presence of an apparently suboptimal CD4 ϩ T cell response. It is well documented that in certain circumstances, CTL induction in vivo requires CD4 ϩ T h cells. For example, the induction of anti-influenza CTL responses in mice primed by immunization with short synthetic peptides representing major CTL determinants of the virus could be completely inhibited by the in vivo depletion of CD4 ϩ T cells (39) . However, compatible with our own findings is the notion that induction of effective CTL responses by viruses is much less helper dependent. In studies examining influenza infection of MHC class II-deficient mice, the CTL activity of lung lavage cells was not diminished compared to infected control mice (40) .
Influenza infection of Rel -/-mice has provided an opportunity to study the functional outcome of a deficit in this transcription factor on both clearance of and protection against viral infection. It now remains to explore issues raised in this study, i.e. the relative contribution of the T h cell deficit to the overall immune deficiency of the Rel -/-mice, and to define any differences in the activity of Rel in CD4 ϩ versus CD8 ϩ T cells both at the functional and molecular levels.
